Pharmacodynamic monitoring of BAY 43-9006 (Sorafenib) in phase I clinical trials involving solid tumor and AML/MDS patients, using flow cytometry to monitor activation of the ERK pathway in peripheral blood cells (Q46961022)
Jump to navigation
Jump to search
scientific article published in May 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacodynamic monitoring of BAY 43-9006 (Sorafenib) in phase I clinical trials involving solid tumor and AML/MDS patients, using flow cytometry to monitor activation of the ERK pathway in peripheral blood cells |
scientific article published in May 2006 |
Statements
1 reference
Pharmacodynamic monitoring of BAY 43-9006 (Sorafenib) in phase I clinical trials involving solid tumor and AML/MDS patients, using flow cytometry to monitor activation of the ERK pathway in peripheral blood cells (English)
1 reference
Frances K Tong
1 reference
Sue Chow
1 reference
1 May 2006
1 reference
70
1 reference
3
1 reference
107-114
1 reference
1 reference
Identifiers
1 reference
1 reference